Similarly, peptides must pass quality checks before theyre ready to use
Published Phase 2 clinical trial data used doses of 1mg, 4mg, 8mg, and 12mg administered weekly via subcutaneous injection
So let's cut through the noise: here's a straight, evidence-based look at what the research actually says, and why it's not something I'd recommend in practice right now
Kim Y, Bark S, Hook V, Bandeira N (2011) NeuroPedia: neuropeptide database and spectral library
Lee et al.'s topical-only approach produced 5272 new hairs a somewhat comparable magnitude from a far simpler intervention
Contact us today to schedule an appointment